What is Abingdon Health Plc (ABDX.L)?

Abingdon Health Plc (ABDX.L) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

Abingdon Health Plc (ABDX.L)

Stock analysis · LSE · Healthcare · Medical - Diagnostics & Research

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.13

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Abingdon Health Plc (ABDX.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Abingdon Health Plc

Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.